Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.58 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | PLG | P00747 | 2/20 | 0.46 |
| ▸ | KLK1 | P06870 | 2/20 | 0.46 |
| ▸ | KLK6 | Q92876 | 2/20 | 0.46 |
| ▸ | ABAT | P80404 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.42 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28861878 | 0.93 | HRH3 (0.64) | IDO1LOXL2HRH3PLGKLK1 | |
| SCHEMBL12636171 | 0.87 | ST14 (0.61) | IDO1LOXL2 | |
| SCHEMBL18232505 | 0.87 | L3MBTL1 (0.54) | IDO1LOXL2PLGKLK1KLK6 | |
| SCHEMBL16557216 | 0.83 | IDO1 (0.52) | IDO1LOXL2PLGKLK1KLK6 | |
| SCHEMBL13189390 | 0.82 | ADRB2 (0.52) | LOXL2HRH3ABATSLC6A2SLC6A3 | |
| SCHEMBL23055189 | 0.80 | HRH3 (0.46) | IDO1LOXL2HRH3ABATSLC6A2 | |
| SCHEMBL11885824 | 0.80 | SLC6A2 (0.68) | SLC6A2SLC6A3TAAR1 | |
| SCHEMBL15820761 | 0.80 | SLC6A2 (0.68) | SLC6A2SLC6A3TAAR1 | |
| SCHEMBL18459578 | 0.80 | SLC6A2 (0.68) | SLC6A2SLC6A3TAAR1 | |
| SCHEMBL7372727 | 0.80 | ABAT (0.48) | LOXL2HRH3PLGKLK1KLK6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 723 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539277-B | 2,4,6, 8-Tetrasubstituted-2, 4,6, 8-tetraazanoradamantan-9-one ethylene glycol | 南京理工大学 | 2024-11-29 | — | — | CN | claimed |
| CN-114539276-B | 2,4,6, 8-Tetrasubstituted-2, 4,6, 8-tetraazaadamantane-9, 10-dione diethylene glycol | 南京理工大学 | 2024-11-29 | — | — | CN | claimed |
| CN-115286527-B | Preparation method and application of nopic acid amide compounds | 南京林业大学 | 2024-09-13 | — | — | CN | claimed |
| CN-118027102-A | Ruthenium complex with enaminone structure, and preparation method and application thereof | 中国科学院理化技术研究所 | 2024-05-14 | — | — | CN | claimed |
| CN-114381247-B | Synthesis of branched epoxy resin pressure-bearing plugging material | 西南石油大学 | 2023-04-25 | — | — | CN | claimed |
| CN-115286527-A | Preparation method and application of nopyl acid amide compounds | 南京林业大学 | 2022-11-04 | — | — | CN | claimed |
| CN-114539276-A | 2,4,6, 8-tetrasubstituted-2, 4,6, 8-tetraazaadamantane-9, 10-dione diethylene glycol | 南京理工大学 | 2022-05-27 | — | — | CN | claimed |
| CN-114539277-A | 2,4,6, 8-tetrasubstituted-2, 4,6, 8-tetraazanoradamantan-9-one ethylene glycol | 南京理工大学 | 2022-05-27 | — | — | CN | claimed |
| CN-114381247-A | Synthesis of branched epoxy resin pressure-bearing plugging material | 西南石油大学 | 2022-04-22 | — | — | CN | claimed |
| CN-113861225-A | Near-infrared emission organic photosensitive molecule, preparation method and application thereof | 扬州工业职业技术学院 | 2021-12-31 | — | — | CN | claimed |
| CN-102276377-B | Method for preparing benzylamine | UNIV ZHEJIANG | 2013-08-07 | — | — | CN | claimed |
| US-8017768-B1 | Catalitic synthesis of caged polynitramine compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2011-09-13 | — | — | US | claimed |
| US-20070066682-A1 | Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus | GENMEDICA THERAPEUTICS SL (ES) | 2007-03-22 | — | — | US | claimed |
| CN-1794989-A | N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes | INST PHARMACEUTICAL DISCOVERY (US) | 2006-06-28 | — | — | CN | claimed |
| CN-1780823-A | Heteroaromatic pentacyclic compound and medicinal use thereof | JAPAN TOBACCO INC (JP) | 2006-05-31 | — | — | CN | claimed |
| US-20050080261-A1 | Purine inhibitors of cyclin dependent kinase 2 and IkappaB-alpha | LUM ROBERT T (US) | 2005-04-14 | — | — | US | claimed |
| EP-0635508-B1 | TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS | ASAHI CHEMICAL IND (JP) | 1999-10-06 | — | — | EP | claimed |
| US-5693794-A | Caged polynitramine compound | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1997-12-02 | — | — | US | claimed |
| US-5621103-A | 3-(SUBSTITUTED METHYLAMINOCARBONYL)-1,2,3,4-TETRAHYDRO-(1)BENZOTHIENO(2,3-C) PYRIDINES; ANXIOLYTIC AGENTS; LEARNING ENHANCEMENT | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1997-04-15 | — | — | US | claimed |
| EP-0635508-A1 | TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1995-01-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066682-A1 | Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus | GPR119, ABCC1, INSR | IDO1 159/4885LOXL2 3562/4885HRH3 1172/4885 |
| US-20050080261-A1 | Purine inhibitors of cyclin dependent kinase 2 and IkappaB-alpha | IKBKB, NFKB1, CDK4 | IDO1 2053/4885LOXL2 2928/4885HRH3 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.